MAPT and Alzheimer disease: The 3xTg-AD mouse model is increasingly used to study AD due to its initial absence of significant physical or behavioral impairments in youth, while progressively developing Aβ plaques (Oddo et al., 2003) and phosphorylated tau (Mandino et al., 2022) as it ages.